Ira Zackon, MD, discussed his retrospective study which aimed to understand patient characteristics, treatment patterns, and OS of patients with higher-risk MDS treated in the community oncology setting.
Belong.Life: Revolutionizing Patient Care with AI Health Mentors
Getting diagnosed with a serious health condition like cancer or multiple sclerosis leaves the patient…